Durability of SARS-CoV-2 IgG response: a cross-sectional study in vaccinated healthcare workers using dried blood spot and multi-antigen profiling

Aim: Assessing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) antibodies among healthcare workers (HCWs) is crucial in understanding the durability of humoral immune response due to vaccination and the post-pandemic era. Therefore, this study aimed to evaluate Ig...

Full description

Saved in:
Bibliographic Details
Main Authors: Imam Nurjaya, Erwin Arief, Nur Ahmad Tabri, Irawaty Djaharuddin, Bulkis Natsir, Sitti Nurisyah, Joko Hendarto, Ansariadi Ansariadi, Rasiha Rasiha, Moh. Anfasa Giffari Makkaraka
Format: Article
Language:English
Published: Open Exploration Publishing Inc. 2024-10-01
Series:Exploration of Immunology
Subjects:
Online Access:https://www.explorationpub.com/Journals/ei/Article/1003166
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850285050843627520
author Imam Nurjaya
Erwin Arief
Nur Ahmad Tabri
Irawaty Djaharuddin
Bulkis Natsir
Sitti Nurisyah
Joko Hendarto
Ansariadi Ansariadi
Rasiha Rasiha
Moh. Anfasa Giffari Makkaraka
author_facet Imam Nurjaya
Erwin Arief
Nur Ahmad Tabri
Irawaty Djaharuddin
Bulkis Natsir
Sitti Nurisyah
Joko Hendarto
Ansariadi Ansariadi
Rasiha Rasiha
Moh. Anfasa Giffari Makkaraka
author_sort Imam Nurjaya
collection DOAJ
description Aim: Assessing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) antibodies among healthcare workers (HCWs) is crucial in understanding the durability of humoral immune response due to vaccination and the post-pandemic era. Therefore, this study aimed to evaluate IgG antibody seroprevalence, IgG levels, and long-term durability responses after the coronavirus disease 2019 (COVID-19) pandemic in HCWs. Methods: The cross-sectional study recruited HCWs aged ≥ 18 years, vaccinated at least once, and without autoimmune diseases at Dr. Wahidin Sudirohusodo Hospital Makassar. Antibody titers against spike protein, nucleocapsid protein, and spike-nucleocapsid conjugate were quantified using dried blood spot (DBS) samples and multi-antigen profiling (xMAP) technology to measure seroprevalence. Results: The results showed that there was a total of 103 participants with the majority being female (59.22%), ≤ 40-year-old (87.38%), nurses (56.31%), had no comorbidities (88.35%), and were infected with COVID-19 (70.87%). A significant proportion received three times vaccination (76.7%), while 102 of 103 (99.03%) showed seropositivity. IgG showed the highest mean antibody titers for spike protein [10,819.38 ± 2,554.23 mean fluorescence intensity (MFI)] in the first 6–12 months after the last vaccinations. Meanwhile, the IgG titer (MFI) showed a long duration over 30 months. Vaccine significantly influenced spike protein antibody levels, with the highest observed in the group receiving a combination of two inactivated vaccines followed by two messenger ribonucleic acid (mRNA) vaccines (p < 0.05). Conclusions: HCWs showed a sustained humoral immune response to SARS-CoV-2 for over 24 months post-vaccination. The type and combination of vaccines administered were significantly correlated with the IgG antibody levels, suggesting the long-term efficacy of the vaccination regimens. The application of DBS and xMAP technology in the study facilitated the assessment of SARS-CoV-2 IgG responses, offering valuable insights into the dynamics of immune persistence following vaccination.
format Article
id doaj-art-2f99bbbf5fdc4b6f8da45fb0cde705d3
institution OA Journals
issn 2768-6655
language English
publishDate 2024-10-01
publisher Open Exploration Publishing Inc.
record_format Article
series Exploration of Immunology
spelling doaj-art-2f99bbbf5fdc4b6f8da45fb0cde705d32025-08-20T01:47:24ZengOpen Exploration Publishing Inc.Exploration of Immunology2768-66552024-10-014567969010.37349/ei.2024.00166Durability of SARS-CoV-2 IgG response: a cross-sectional study in vaccinated healthcare workers using dried blood spot and multi-antigen profilingImam Nurjaya0https://orcid.org/0009-0007-3155-1680Erwin Arief1https://orcid.org/0000-0003-0108-1554Nur Ahmad Tabri2https://orcid.org/0000-0001-9012-7475Irawaty Djaharuddin3https://orcid.org/0000-0002-5240-4950Bulkis Natsir4https://orcid.org/0009-0005-2249-4114Sitti Nurisyah5https://orcid.org/0000-0003-2285-7286Joko Hendarto6https://orcid.org/0000-0002-2148-4353Ansariadi Ansariadi7https://orcid.org/0000-0002-9692-6136Rasiha Rasiha8https://orcid.org/0000-0002-3944-9556Moh. Anfasa Giffari Makkaraka9https://orcid.org/0000-0003-1179-5366Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia; Department of Pulmonology, Dr. Wahidin Sudirohusodo Hospital, Makassar 90245, IndonesiaDepartment of Pulmonology and Respiratory Medicine, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia; Department of Pulmonology, Dr. Wahidin Sudirohusodo Hospital, Makassar 90245, IndonesiaDepartment of Pulmonology and Respiratory Medicine, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia; Department of Pulmonology, Dr. Wahidin Sudirohusodo Hospital, Makassar 90245, IndonesiaDepartment of Pulmonology and Respiratory Medicine, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia; Department of Pulmonology, Dr. Wahidin Sudirohusodo Hospital, Makassar 90245, IndonesiaDepartment of Pulmonology and Respiratory Medicine, Faculty of Medicine, Hasanuddin University, Makassar 90245, IndonesiaDepartment of Pulmonology and Respiratory Medicine, Faculty of Medicine, Hasanuddin University, Makassar 90245, IndonesiaDepartment of Pulmonology and Respiratory Medicine, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia; Department of Pulmonology, Dr. Wahidin Sudirohusodo Hospital, Makassar 90245, IndonesiaDepartment of Epidemiology, Faculty of Public Health, Hasanuddin University, Makassar 90245, IndonesiaFaculty of Medicine, Hasanuddin University, Makassar 90245, IndonesiaFaculty of Medicine, Hasanuddin University, Makassar 90245, IndonesiaAim: Assessing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) antibodies among healthcare workers (HCWs) is crucial in understanding the durability of humoral immune response due to vaccination and the post-pandemic era. Therefore, this study aimed to evaluate IgG antibody seroprevalence, IgG levels, and long-term durability responses after the coronavirus disease 2019 (COVID-19) pandemic in HCWs. Methods: The cross-sectional study recruited HCWs aged ≥ 18 years, vaccinated at least once, and without autoimmune diseases at Dr. Wahidin Sudirohusodo Hospital Makassar. Antibody titers against spike protein, nucleocapsid protein, and spike-nucleocapsid conjugate were quantified using dried blood spot (DBS) samples and multi-antigen profiling (xMAP) technology to measure seroprevalence. Results: The results showed that there was a total of 103 participants with the majority being female (59.22%), ≤ 40-year-old (87.38%), nurses (56.31%), had no comorbidities (88.35%), and were infected with COVID-19 (70.87%). A significant proportion received three times vaccination (76.7%), while 102 of 103 (99.03%) showed seropositivity. IgG showed the highest mean antibody titers for spike protein [10,819.38 ± 2,554.23 mean fluorescence intensity (MFI)] in the first 6–12 months after the last vaccinations. Meanwhile, the IgG titer (MFI) showed a long duration over 30 months. Vaccine significantly influenced spike protein antibody levels, with the highest observed in the group receiving a combination of two inactivated vaccines followed by two messenger ribonucleic acid (mRNA) vaccines (p < 0.05). Conclusions: HCWs showed a sustained humoral immune response to SARS-CoV-2 for over 24 months post-vaccination. The type and combination of vaccines administered were significantly correlated with the IgG antibody levels, suggesting the long-term efficacy of the vaccination regimens. The application of DBS and xMAP technology in the study facilitated the assessment of SARS-CoV-2 IgG responses, offering valuable insights into the dynamics of immune persistence following vaccination.https://www.explorationpub.com/Journals/ei/Article/1003166sars-cov-2vaccineimmunoglobulin ghealthcare worker
spellingShingle Imam Nurjaya
Erwin Arief
Nur Ahmad Tabri
Irawaty Djaharuddin
Bulkis Natsir
Sitti Nurisyah
Joko Hendarto
Ansariadi Ansariadi
Rasiha Rasiha
Moh. Anfasa Giffari Makkaraka
Durability of SARS-CoV-2 IgG response: a cross-sectional study in vaccinated healthcare workers using dried blood spot and multi-antigen profiling
Exploration of Immunology
sars-cov-2
vaccine
immunoglobulin g
healthcare worker
title Durability of SARS-CoV-2 IgG response: a cross-sectional study in vaccinated healthcare workers using dried blood spot and multi-antigen profiling
title_full Durability of SARS-CoV-2 IgG response: a cross-sectional study in vaccinated healthcare workers using dried blood spot and multi-antigen profiling
title_fullStr Durability of SARS-CoV-2 IgG response: a cross-sectional study in vaccinated healthcare workers using dried blood spot and multi-antigen profiling
title_full_unstemmed Durability of SARS-CoV-2 IgG response: a cross-sectional study in vaccinated healthcare workers using dried blood spot and multi-antigen profiling
title_short Durability of SARS-CoV-2 IgG response: a cross-sectional study in vaccinated healthcare workers using dried blood spot and multi-antigen profiling
title_sort durability of sars cov 2 igg response a cross sectional study in vaccinated healthcare workers using dried blood spot and multi antigen profiling
topic sars-cov-2
vaccine
immunoglobulin g
healthcare worker
url https://www.explorationpub.com/Journals/ei/Article/1003166
work_keys_str_mv AT imamnurjaya durabilityofsarscov2iggresponseacrosssectionalstudyinvaccinatedhealthcareworkersusingdriedbloodspotandmultiantigenprofiling
AT erwinarief durabilityofsarscov2iggresponseacrosssectionalstudyinvaccinatedhealthcareworkersusingdriedbloodspotandmultiantigenprofiling
AT nurahmadtabri durabilityofsarscov2iggresponseacrosssectionalstudyinvaccinatedhealthcareworkersusingdriedbloodspotandmultiantigenprofiling
AT irawatydjaharuddin durabilityofsarscov2iggresponseacrosssectionalstudyinvaccinatedhealthcareworkersusingdriedbloodspotandmultiantigenprofiling
AT bulkisnatsir durabilityofsarscov2iggresponseacrosssectionalstudyinvaccinatedhealthcareworkersusingdriedbloodspotandmultiantigenprofiling
AT sittinurisyah durabilityofsarscov2iggresponseacrosssectionalstudyinvaccinatedhealthcareworkersusingdriedbloodspotandmultiantigenprofiling
AT jokohendarto durabilityofsarscov2iggresponseacrosssectionalstudyinvaccinatedhealthcareworkersusingdriedbloodspotandmultiantigenprofiling
AT ansariadiansariadi durabilityofsarscov2iggresponseacrosssectionalstudyinvaccinatedhealthcareworkersusingdriedbloodspotandmultiantigenprofiling
AT rasiharasiha durabilityofsarscov2iggresponseacrosssectionalstudyinvaccinatedhealthcareworkersusingdriedbloodspotandmultiantigenprofiling
AT mohanfasagiffarimakkaraka durabilityofsarscov2iggresponseacrosssectionalstudyinvaccinatedhealthcareworkersusingdriedbloodspotandmultiantigenprofiling